The influence of newly developed oximes, K027 [1-(4-hydroxyiminomethylpyridinium)-3-(4-carbamoylpyridinium) propane dibromide] and K048 [1-(4-hydroxyiminomethylpyridinium)-3-(4-carbamoylpyridinium) butane dibromide], or currently used oximes (pralidoxime, obidoxime, trimedoxime, HI-6) and anticholinergic drugs (atropine, benactyzine) on the ability of antidotal treatment to eliminate tabun-induced acute toxic effects was studied in mice. The therapeutical efficacy of trimedoxime and both newly developed oximes (K027, K048) is significantly higher than the potency of pralidoxime (regardless of the choice of anticholinergic drug), obidoxime (in the case of its combination with atropine) and the oxime HI-6 (in the case of its combination with benactyzine). All studied oximes with the exception of pralidoxime and the oxime HI-6, when combined with benactyzine, appear to be more efficacious in the elimination of toxic effects of the lethal dose of tabun than their combination with atropine. The findings support the hypothesis that the choice of acetylcholinesterase reactivators as well as the anticholinergic drug selection are important for the effectiveness of an antidotal mixture in the case of antidotal treatment of tabun-induced acute poisonings.

Department of Toxikology Faculty of Military Health Sciences P O Box 35 T 500 01 Hradec Kralove Czech Republic

Zobrazit více v PubMed

Adv Clin Chem. 2004;38:151-216 PubMed

Bioorg Med Chem Lett. 2003 Oct 20;13(20):3545-7 PubMed

J Toxicol Clin Toxicol. 2002;40(6):803-16 PubMed

J Enzyme Inhib Med Chem. 2003 Dec;18(6):529-35 PubMed

Toxicol Lett. 1996 Apr;85(1):35-9 PubMed

Vet Hum Toxicol. 2004 Feb;46(1):15-8 PubMed

Acta Medica (Hradec Kralove). 2004;47(2):111-4 PubMed

Basic Clin Pharmacol Toxicol. 2004 Aug;95(2):81-6 PubMed

Acta Medica (Hradec Kralove). 2001;44(2):77-9 PubMed

Biopharm Drug Dispos. 1993 Nov;14(8):673-84 PubMed

Res Commun Chem Pathol Pharmacol. 1990 Sep;69(3):261-70 PubMed

In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterases

Reactivation of sarin-inhibited pig brain acetylcholinesterase using oxime antidotes

The acute toxicity of acetylcholinesterase reactivators in mice in relation to their structure